DPP4 and prostate carcinoma: Various malignancies have been shown to express CD26, e.g., hepatocellular carcinoma, thyroid carcinoma, renal cell carcinoma, prostate cancer, gastrointestinal tumors, malignant mesothelioma, and some hematologic malignancies (22).